Fig. 8From: Feikang granules ameliorate pulmonary inflammation in the rat model of chronic obstructive pulmonary disease via TLR2/4-mediated NF-κB pathwayExpression of TLR2, TLR4, p-IkappaB, IkappaB and P65 in lung tissues of COPD rats in each group. 1: Normal control rats, 2: COPD model rats without any treatment, 3: low dose of Feikang granules groups, 4: medium dose of Feikang granules groups, 5: high dose of Feikang granules groups, 6: dexamethasone groupBack to article page